1/40
Looks like no tags are added yet.
The study of the use of and the effects of drugs in large numbers of people
Pharmacoepidemiology
the study of the effect of Rx (medications)
pharmacology
is the study of the distribution and determinants of disease in the population
epidemiology
Why is Pharmacoepi Important?
-population aging
-disease management
-more drugs
-inadequacy of systems
-growing emphasis on patient safety
-regulation and accreditation
-managed care
• Pharmacoepidemiology studies:
- Quantify drug use patterns
- Quantify adverse drug effects
Evaluate acute and short-term toxicity in animals:
• Dose at increasingly high levels to induce toxicity • Determine the lethal dose • Dose at normal levels for short and long term
Pre-clinical
Assess how the drug is absorbed, distributed, metabolized, and excreted in animals
pre-clinical
How long is pre-clinical?
3-6 years
Measurable Drug Effects:
-Anticipated beneficial effects
--Efficacy versus effectiveness
-Unanticipated beneficial effects
-Unanticipated harmful effects
-Anticipated harmful effects
-Determine saf and dosage
phase 1
Evaluate efficacy and side effects
phase 2
Verify efficacy
phase 3
How Do We Fill in These Gaps?
Pharmacoepidemiology
o Phase IV research
Benefits and Risks
o PharmEpi Research
o Pharmacovigilance / Surveillance
o Safety / Risk Management
frequency an event occurs in a population at risk during a specified time
rates
numerator and denominator always related and expressed as a percentage
proportions
Rates:
number of events/population at risk
q Popular measures for quantifying morbidity at population level are:
incidence
prevalence
Number of new cases that occurs [numerator] in a population at risk for developing the disease [denominator] during a specified time period ( annually)
incidence
Measures the rapidity with which a new condition develops in a populations (growth or flow)
incidence
Useful for studying the cause of disease and evaluating effectiveness of programs to prevent disease from developing
incidence
is the number of new cases over a specified time period divided by the size of the population initially at risk.
cumulative incidence
This is used when the at-risk population observed is constant during the period of measurement
cumulative incidence
Cumulative incidence equation:
number of new cases of disease during period / number at risk during a period
q Number of new cases per population at risk in a given time period
incidence rate
o Study population is dynamic
incidence rate
o Measures how fast new cases of a disease occur (rapidity of new cases of an event)
incidence rate
Incidence rate:
number of new cases/total person time
Measures the number of new cases of disease during a specified period of time as a proportion of the total time at which individuals in a population at risk are observed
incidence rate
the snapshot of health-related (old and new) cases in a population at a particular point or period in time.
prevalence
The number of named disease or drug related cases ( old and new) at a point or period in time
prevalence
Range of measure for prevalence:
0 to 1
is the number of persons with disease in a time interval (eg, one year) divided by number of persons in the population; that is, prevalence at the beginning of an interval plus any incident cases.
point prevalence
The calculation of _____ is based on a single examination at one point in time (snapshot in time)
point prevalence
point prevalence equation:
Number of persons with the case at a specified time/ number in the population at that time
Tells us how much of a disease is present in a population over a period of time
period prevalence
A condition with high incidence and long duration will have high what?
prevalence
CMR equation:
total number of deaths during year/ number of people in population during year
q Total number of deaths from all causes among individuals in a specific age category
Age-specific mortality rate
q Total number of deaths from a specific cause during a specific time period
Cause specific mortality rate
Limitation of cause specific mortality
q Limitation - miscoded or misclassified
cause-specific mortality rate equation:
(number of deaths due to a particular cause during a specified period) / the population during that period) x 1,000